Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
Clot Retraction and Fibrinolysis01:16

Clot Retraction and Fibrinolysis

After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
Extrinsic and Intrinsic Pathways of Hemostasis01:20

Extrinsic and Intrinsic Pathways of Hemostasis

Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...
Venous Thrombosis I: Introduction01:30

Venous Thrombosis I: Introduction

Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
Intracellular Signaling Affects Focal Adhesions01:17

Intracellular Signaling Affects Focal Adhesions

Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Predictive modeling in biology and medicine: Digital twins and multi-scale modeling.

PLoS computational biology·2026
Same author

Epigenetic Perspectives on Maternal Gut Microbiota's Impact on Embryonic and Fetal Development.

Comprehensive Physiology·2026
Same author

Ginkgo biloba extract suppresses hepatocellular carcinoma progression by inhibiting the recruitment of myeloid-derived suppressor cells through reduced CXCL1 secretion via SRC downregulation.

Frontiers in immunology·2026
Same author

Engineered VPg saRNA achieves cap-independent, low-immunogenic and precise encoding of therapeutic proteins in vivo.

Nature communications·2026
Same author

Tmem110 regulates the conformation of TRPML1 to maintain endolysosomal homeostasis and prevent mitochondrial DNA leakage and pathological self-DNA processing.

Nature communications·2026
Same author

A bibliometric analysis of 2000-2024 on interventional therapy for liver cancer and tumor immune microenvironment.

Chinese clinical oncology·2026
Same journal

Tools for computational analysis of moving boundary problems in cellular mechanobiology.

Wiley interdisciplinary reviews. Systems biology and medicine·2020
Same journal

Cellular reprogramming: Mathematics meets medicine.

Wiley interdisciplinary reviews. Systems biology and medicine·2020
Same journal

Thermoregulation: A journey from physiology to computational models and the intensive care unit.

Wiley interdisciplinary reviews. Systems biology and medicine·2020
Same journal

Mammalian cell and tissue imaging using Raman and coherent Raman microscopy.

Wiley interdisciplinary reviews. Systems biology and medicine·2020
Same journal

Regulating cellular cyclic adenosine monophosphate: "Sources," "sinks," and now, "tunable valves".

Wiley interdisciplinary reviews. Systems biology and medicine·2020
Same journal

Molecular networks in Network Medicine: Development and applications.

Wiley interdisciplinary reviews. Systems biology and medicine·2020
See all related articles

Related Experiment Video

Updated: May 25, 2026

Thrombus Profiling Assay: A Microfluidics-Based Platform for Comprehensively Characterizing Biomechanical Thrombogenesis
08:50

Thrombus Profiling Assay: A Microfluidics-Based Platform for Comprehensively Characterizing Biomechanical Thrombogenesis

Published on: January 9, 2026

Multiscale models of thrombogenesis.

Zhiliang Xu1, Oleg Kim, Malgorzata Kamocka

  • 1Department of Applied and Computational Mathematics and Statistics, University of Notre Dame, Notre Dame, IN, USA.

Wiley Interdisciplinary Reviews. Systems Biology and Medicine
|January 17, 2012
PubMed
Summary
This summary is machine-generated.

This study reviews computational models of blood clot formation (thrombosis). Understanding these processes is crucial for developing predictive simulations to assess thrombotic risk and prevent related diseases.

More Related Videos

In Vitro Microfluidic Disease Model to Study Whole Blood-Endothelial Interactions and Blood Clot Dynamics in Real-Time
09:19

In Vitro Microfluidic Disease Model to Study Whole Blood-Endothelial Interactions and Blood Clot Dynamics in Real-Time

Published on: May 24, 2020

Ferric Chloride-induced Murine Thrombosis Models
10:37

Ferric Chloride-induced Murine Thrombosis Models

Published on: September 5, 2016

Related Experiment Videos

Last Updated: May 25, 2026

Thrombus Profiling Assay: A Microfluidics-Based Platform for Comprehensively Characterizing Biomechanical Thrombogenesis
08:50

Thrombus Profiling Assay: A Microfluidics-Based Platform for Comprehensively Characterizing Biomechanical Thrombogenesis

Published on: January 9, 2026

In Vitro Microfluidic Disease Model to Study Whole Blood-Endothelial Interactions and Blood Clot Dynamics in Real-Time
09:19

In Vitro Microfluidic Disease Model to Study Whole Blood-Endothelial Interactions and Blood Clot Dynamics in Real-Time

Published on: May 24, 2020

Ferric Chloride-induced Murine Thrombosis Models
10:37

Ferric Chloride-induced Murine Thrombosis Models

Published on: September 5, 2016

Area of Science:

  • Biomedical Engineering
  • Computational Biology
  • Hematology

Background:

  • Blood clots (thrombi) are essential for hemostasis but pathological clotting causes significant mortality.
  • Vessel obstruction by thrombi or emboli leads to conditions like stroke and pulmonary embolism.
  • Venous thromboembolic disease is a major cause of hospitalization and death, with increasing incidence.

Purpose of the Study:

  • To review computational models of key hemostasis/thrombosis subprocesses.
  • To describe multiscale models integrating these subprocesses for thrombus development simulation.
  • To highlight the value of computational models for understanding thrombotic risk.

Main Methods:

  • Review of computational models for coagulation reactions, platelet activation, and fibrin assembly.
  • Description of multiscale models integrating these subprocesses.
  • Focus on temporal and spatial development of thrombi.

Main Results:

  • Computational models exist for individual hemostasis/thrombosis subprocesses.
  • Multiscale models integrate these subprocesses to simulate thrombus development.
  • These models offer insights into the interplay of hemostatic factors.

Conclusions:

  • Validated computational models and predictive simulations are valuable tools for thrombosis research.
  • These models can explore how variations in hemostatic factors influence thrombotic risk.
  • Advancing computational approaches is key to mitigating thrombosis-related mortality.